The Global Digital Biomarkers Market size is expected to grow from USD 3.56 billion in 2023 to USD 75.61 billion by 2032, at a CAGR of 40.43% during the forecast period (2024-2032) Digital biomarkers have a significant benefit in their capacity to collect data constantly in real-time, providing a more thorough and dynamic understanding of an individual's health in contrast to occasional clinic appointments or conventional testing procedures. This ongoing observation can facilitate timely identification of health problems, individualized treatments, and more accurate control of chronic conditions. Additionally, digital biomarkers make it easier to monitor patients remotely, which is becoming more important in a healthcare system that is shifting towards decentralized care and telemedicine. The latest research on the Digital Biomarkers market provides a comprehensive overview of the market for the years 2024 to 2032. It gives a comprehensive picture of the global Digital Bio